Panacea Biotec enters in joint collaboration with Bionpharma Inc.

For development, license, manufacturing, supply and sales of 7 generic products

Panacea Biotec has entered into joint collaboration for development, license, manufacturing, supply and sales of 7 complex generic pharmaceutical products with Bionpharma Inc., a generic pharmaceutical company based in the United States.

Under the collaboration, Panacea Biotec will be responsible for the development, filing, registration, manufacturing and supply of these ANDAs.

Bionpharma Inc. will be responsible for importation, warehousing, sales and distribution of these ANDAs in the United States and its territories

Both companies intend to expand the scope of their alliance by adding new products to the collaboration from time to time.

Powered by Capital Market - Live News